JFJordan FeldMD, MPHSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2019Hypothesized Synergies in new cobmination treatment beyond nucs- Jordan Feld, MD, MPHView Slideset
MPMarion PetersMDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2019Study Design with New Combinations- Marion Peters, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2019NAP's latest update in HBV and HDV- Andrew VaillantView Slideset
RGRobert GishMDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2019HDV Trials- Robert GishView Slideset
MBMichael BiermerMDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2019sIRNA based therapy for Chronic Hepatitis B Treatment- Michael BiermerView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2019Elimination of Residual HBV Replication and Prevention of cccDNA Generation with the Combination of NrtI and Core Inhibitor- Richard ColonnoView Slideset
AGAdam GehringPhDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2019Using FNAB to Investigate Intrahepatic Immunology- Adam Gehring, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2019Roche TLR-7 agonist- Lu GaoView Slideset
FvBFlorian van BommelMDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2019Are HBcrAg, HBV RNA and anti-HBc Viable Biomarkers- Florian van Bommel, MDView Slideset
